| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |